Selective Internal Radiation Therapy With Yttrium-90 Glass Microspheres: Biases and Uncertainties in Absorbed Dose Calculations Between Clinical Dosimetry Models

被引:30
|
作者
Mikell, Justin K. [1 ,5 ]
Mahvash, Armeen [2 ]
Siman, Wendy [1 ,5 ]
Baladandayuthapani, Veera [3 ,5 ]
Mourtada, Firas [4 ,6 ,7 ]
Kappadath, S. Cheenu [1 ,5 ]
机构
[1] Univ Texas MD Anderson Canc Ctr, Dept Imaging Phys, Houston, TX 77030 USA
[2] Univ Texas MD Anderson Canc Ctr, Dept Intervent Radiol, Houston, TX 77030 USA
[3] Univ Texas MD Anderson Canc Ctr, Dept Biostat, Houston, TX 77030 USA
[4] Univ Texas MD Anderson Canc Ctr, Dept Radiat Phys, Houston, TX 77030 USA
[5] Univ Texas Grad Sch Biomed Sci Houston, Houston, TX USA
[6] Christiana Care, Dept Radiat Oncol, Newark, DE USA
[7] Thomas Jefferson Univ, Dept Radiat Oncol, Philadelphia, PA 19107 USA
基金
美国国家卫生研究院;
关键词
HEPATOCELLULAR-CARCINOMA PATIENTS; TREATMENT PLANNING STRATEGY; METASTATIC LIVER-CANCER; TC-99M MAA; RADIOEMBOLIZATION; SPECT; HEPATOCARCINOMA; PREDICTS; SURVIVAL; EFFICACY;
D O I
10.1016/j.ijrobp.2016.07.021
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: To quantify differences that exist between dosimetry models used for Y-90 selective internal radiation therapy (SIRT). Methods and Materials: Retrospectively, 37 tumors were delineated on 19 post- therapy quantitative Y-90 single photon emission computed tomography/computed tomography scans. Using matched volumes of interest (VOIs), absorbed doses were reported using 3 dosimetry models: glass microsphere package insert standard model (SM), partition model (PM), and Monte Carlo (MC). Univariate linear regressions were performed to predict mean MC from SM and PM. Analysis was performed for 2 subsets: cases with a single tumor delineated (best case for PM), and cases with multiple tumors delineated (typical clinical scenario). Variability in PM from the ad hoc placement of a single spherical VOI to estimate the entire normal liver activity concentration for tumor (T) to nontumoral liver (NL) ratios (TNR) was investigated. We interpreted the slope of the resulting regression as bias and the 95% prediction interval (95% PI) as uncertainty. MCNLsingle represents MC absorbed doses to the NL for the single tumor patient subset; other combinations of calculations follow a similar naming convention. Results: SM was unable to predict MCTsingle or MCTmultiple (p>.12, 95% PI > +/- 177 Gy). However, SMsingle was able to predict (p<.012) MCNLsingle , albeit with large uncertainties; SMsingle and SMmultiple yielded biases of 0.62 and 0.71, and 95% PI of +/- 40 and +/- 32 Gy, respectively. PMTsingle and PMTmultiple predicted (p< 2E-6) MC(T)(single)and MCTmultiple with biases of 0.52 and 0.54, and 95% PI of +/- 38 and +/- 111 Gy, respectively. The TNR variability in PMTsingle increased the 95% PI for predicting MCTsingle (bias = 0.46 and 95% PI = +/- 103 Gy). The TNR variability in PMTmultiple modified the bias when predicting MCTmultiple (bias = 0.32 and 95% PI = +/- 110 Gy). Conclusions: The SM is unable to predict mean MC tumor absorbed dose. The PM is statistically correlated with mean MC, but the resulting uncertainties in predicted MC are large. Large differences observed between dosimetry models for Y-90 SIRT warrant caution when interpreting published SIRT absorbed doses. To reduce uncertainty, we suggest the entire NLVOI be used for TNR estimates when using PM. (C) 2016 Elsevier Inc. All rights reserved.
引用
收藏
页码:888 / 896
页数:9
相关论文
共 50 条
  • [31] International recommendations for personalised selective internal radiation therapy of primary and metastatic liver diseases with yttrium-90 resin microspheres
    Hugo Levillain
    Oreste Bagni
    Christophe M. Deroose
    Arnaud Dieudonné
    Silvano Gnesin
    Oliver S. Grosser
    S. Cheenu Kappadath
    Andrew Kennedy
    Nima Kokabi
    David M. Liu
    David C. Madoff
    Armeen Mahvash
    Antonio Martinez de la Cuesta
    David C. E. Ng
    Philipp M. Paprottka
    Cinzia Pettinato
    Macarena Rodríguez-Fraile
    Riad Salem
    Bruno Sangro
    Lidia Strigari
    Daniel Y. Sze
    Berlinda J. de Wit van der veen
    Patrick Flamen
    European Journal of Nuclear Medicine and Molecular Imaging, 2021, 48 : 1570 - 1584
  • [32] International recommendations for personalised selective internal radiation therapy of primary and metastatic liver diseases with yttrium-90 resin microspheres
    Levillain, Hugo
    Bagni, Oreste
    Deroose, Christophe M.
    Dieudonne, Arnaud
    Gnesin, Silvano
    Grosser, Oliver S.
    Kappadath, S. Cheenu
    Kennedy, Andrew
    Kokabi, Nima
    Liu, David M.
    Madoff, David C.
    Mahvash, Armeen
    Martinez de la Cuesta, Antonio
    Ng, David C. E.
    Paprottka, Philipp M.
    Pettinato, Cinzia
    Rodriguez-Fraile, Macarena
    Salem, Riad
    Sangro, Bruno
    Strigari, Lidia
    Sze, Daniel Y.
    de Wit van der Veen, Berlinda J.
    Flamen, Patrick
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2021, 48 (05) : 1570 - 1584
  • [33] Combined Yttrium-90 microsphere selective internal radiation therapy and external beam radiotherapy in patients with hepatocellular carcinoma: From clinical aspects to dosimetry
    Wang, Ti-Hao
    Huang, Pin-I
    Hu, Yu-Wen
    Lin, Ko-Han
    Liu, Ching-Sheng
    Lin, Yi-Yang
    Liu, Chien-An
    Tseng, Hsiou-Shan
    LiU, Yu-Ming
    Lee, Rheun-Chuan
    PLOS ONE, 2018, 13 (01):
  • [34] Partition model for accurate radiation therapy with yttrium-90 Glass microspheres in hepatocellular carcinoma.
    Adib, S.
    Monteiro, M.
    Gnesin, S.
    Bize, P.
    Denys, A.
    Prior, J.
    Boubaker, A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2015, 42 : S755 - S755
  • [35] Selective Internal Radiation Therapy/Yttrium-90: Have We Found Its Place?
    Harrold, Emily C.
    Nicholson, Patrick J.
    Tuite, David J.
    Power, Derek G.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (34)
  • [36] Liver Resection After Selective Internal Radiation Therapy with Yttrium-90: Safety and Outcomes
    Mafeld, Sebastian
    Littler, Peter
    Hayhurst, Hannah
    Manas, Derek
    Jackson, Ralph
    Moir, John
    French, Jeremy
    JOURNAL OF GASTROINTESTINAL CANCER, 2020, 51 (01) : 152 - 158
  • [37] Liver Resection After Selective Internal Radiation Therapy with Yttrium-90: Safety and Outcomes
    Sebastian Mafeld
    Peter Littler
    Hannah Hayhurst
    Derek Manas
    Ralph Jackson
    John Moir
    Jeremy French
    Journal of Gastrointestinal Cancer, 2020, 51 : 152 - 158
  • [38] Evaluation of Eclipse Smart Segmentation for Liver Yttrium-90 Selective Internal Radiation Therapy
    Li, J.
    Anne, R.
    MEDICAL PHYSICS, 2021, 48 (06)
  • [39] Selective Internal Radiation Therapy with Yttrium-90 for Intrahepatic Cholangiocarcinoma: A Systematic Review on Post-Treatment Dosimetry and Concomitant Chemotherapy
    Hosseini Shabanan, Sedighe
    Nezami, Nariman
    Abdelsalam, Mohamed E.
    Sheth, Rahul Anil
    Odisio, Bruno C.
    Mahvash, Armeen
    Habibollahi, Peiman
    CURRENT ONCOLOGY, 2022, 29 (06) : 3825 - 3848
  • [40] HCC Locoregional Therapies: Yttrium-90 (Y-90) Selective Internal Radiation Therapy (SIRT)
    Güney İ.B.
    Journal of Gastrointestinal Cancer, 2017, 48 (3) : 276 - 280